Nanomaterial: A realistic business case for Pharma
Authors:
T.H. Keller
Affilation:
GlaxoSmithKline, UK
Pages:
190 - 193
Keywords:
nanomaterials, targeted drug delivery
Abstract:
Main points from a pharma perspective: Review nanotech’s current position Nanotech and its realistic potential Nanotech and the barriers into the clinic GSK’s position on the subject matter
